U.S. Surgeon General Vivek Murthy is assuring parents that regulators won't take shortcuts in authorizing a COVID-19 vaccine from Pfizer-BioNTech for kids younger than 5 as the Food and Drug Administration employs a two-step process to get a jump-start on the rollout.
U.S. Surgeon General Vivek Murthy is assuring parents that regulators won't take shortcuts in authorizing a COVID-19 vaccine from Pfizer-BioNTech for kids younger than 5 as the Food and Drug Administration employs a two-step process to get a jump-start on the rollout.
U.S. regulators are planning to review and authorize Pfizer and BioNTech's COVID-19 vaccine for children younger than 5 before data on a third and potentially necessary shot is available.
U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children six months to 5 years old while awaiting data on a three-dose course, aiming to clear the way for the shots as soon as late February, a person familiar with the matter told The Associated Press Monday.